About Testis-specific Y-encoded-like protein 5
Testis-specific Y-encoded-like protein 5 (TSPYL5) is a protein
from Homo sapiens identified by UniProt accession
Q86VY4, 417 residues long.
MolForge cross-references it against 0 known binders and
55 disease associations.
Target properties
| Protein name | Testis-specific Y-encoded-like protein 5 |
| UniProt accession | Q86VY4 |
| Gene | TSPYL5 |
| Organism | Homo sapiens |
| Length | 417 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (55)
Diseases linked to this target (Open Targets).
- estradiol measurement · score 0.28
- basal cell carcinoma · score 0.27
- keratinocyte carcinoma · score 0.27
- migraine disorder · score 0.12
- hepatocellular carcinoma · score 0.08
- non-small cell lung carcinoma · score 0.07
- blood protein measurement · score 0.06
- cancer · score 0.06
- neoplasm · score 0.05
- Ataxia-telangiectasia · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86VY4-F1 | alphafold | PREDICTED | 61.86 | — |
Amino-acid sequence (417 residues)
MSGRSRGRKS SRAKNRGKGR AKARVRPAPD DAPRDPDPSQ YQSLGEDTQA AQVQAGAGWG GLEAAASAQL LRLGEEAACR LPLDCGLALR ARAAGDHGQA AARPGPGKAA SLSERLAADT VFVGTAGTVG RPKNAPRVGN RRGPAGKKAP ETCSTAGRGP QVIAGGRQKK GAAGENTSVS AGEEKKEERD AGSGPPATEG SMDTLENVQL KLENMNAQAD RAYLRLSRKF GQLRLQHLER RNHLIQNIPG FWGQAFQNHP QLASFLNSQE KEVLSYLNSL EVEELGLARL GYKIKFYFDR NPYFQNKVLI KEYGCGPSGQ VVSRSTPIQW LPGHDLQSLS QGNPENNRSF FGWFSNHSSI ESDKIVEIIN EELWPNPLQF YLLSEGARVE KGKEKEGRQG PGKQPMETTQ PGVSQSN
Explore Testis-specific Y-encoded-like protein 5 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets